Danica Giugliano
Colon & Rectal Surgery · Camden, NJNPI 1073870010
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (48.0%), education and travel and lodging — rather than concentrated in one kind of arrangement. Intuitive Surgical accounts for 61.9% of it on its own, with 9 other manufacturers making up the rest. Reporting peaked in 2019 at $1,865 and has fallen 80.5% since, to $363 in 2025.
Across 30 payments — averaging $125.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$2K
- Medtronic$614
- Takeda Pharmaceuticals U.S.A., Inc.$205
- Integra Lifesciences Corporation$168
- Davol Inc.$125
- Baxter Healthcare$124
- plus $200 from 4 others
What the payments were for
- Travel & lodging$94625%
- Food & beverage$1,80948%
- Education$1,00027%
- Gifts$160%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 13 | $2,334 |
| Medtronic | 7 | $614 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $205 |
| Integra Lifesciences Corporation | 1 | $168 |
| Davol Inc. | 2 | $125 |
| Baxter Healthcare | 1 | $124 |
| Olympus America Inc. | 1 | $98 |
| Teleflex LLC | 1 | $70 |
| Lilly USA, LLC | 1 | $17 |
| Steris Corporation | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Da Vinci Surgical System$2,185
- INTEGRA$505
- EEA$173
- INTEGRA DERMAL REGENERATION TEMPLATE$168
- PRIMATRIX$168
- Signia$129
- Entyvio$103
- GATTEX$103
How this compares
$3,771 in reported general payments places this provider in the 65th percentile of 86 colon & rectal surgery providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Neomycin Sulfate | 14 | $51 |
| Metronidazole | 15 | $14 |
Paid to pharmacies, not to this prescriber.
Other colon & rectal surgery in Camden
- Laura GrecoCamden$3K
- Steven Lee-KongHackensack$55K
- Ashlee Godshalk RugglesPennington$44K
- John BerryPennington$36K
- Thomas LakeOakhurst$15K
- Glenn ParkerOakhurst$14K
- Daniel FeingoldNew Brunswick$14K
- Kulvir NandraGlen Ridge$12K
- Michele MalitHolmdel$11K
- Brendan ScullyNew Brunswick$11K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.